Profits from investments and other exceptional gains helped India's largest multinational drug company Glaxo Pharmaceuticals post a 157 per cent higher net profit at Rs 208.4 crore for the fourth quarter ended December 2008, compared with Rs 80.9 crore for the corresponding previous quarter in 2007.
Total income for the fourth quarter was at Rs 375.5 crore, 5.15 per cent higher than the Rs 357.1 crore for the fourth quarter in 2007, according to unaudited results for the quarter.
Consolidated net profit was up by 7.94 per cent at Rs 591 crore for the year ended December, 2008, where as the same was at Rs 547.5 crore for the previous year. GSK India generated a total income of Rs 1,742.6 crore for the year ended December 31, 2008, 5.31 per cent higher than the Rs 1,654.6 crore income for the year ended December 31, 2007.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app